QbD Ecosystem


Alone you can do something, together you can do anything.

This is why QbD believes in strong, complementary partnerships. QbD’s complete ecosystem offers knowledge in development, clinical, regulatory & compliance, production, and distribution for companies active in Pharma, Biotech, and Medical Devices.

Via its strong partnerships, QbD can also offer you services and solutions in complementary areas of specialization.

Quality by design home

An overview of our ecosystem

Other companies in the QbD Group


Qarad brings 35 years of expertise in Regulatory Affairs and Quality Assurance regarding In Vitro Diagnostic Devices – which is regulated by the specific IVD Regulation (IVDR) – to the group. Its activities consist of consultancy and other services regarding CE Marking and Quality Systems and Electronic Instructions for Use.


Quercus is a GMP certified contract laboratory. Our customers are pharmaceutical companies, and other life science and health industries, such as companies involved in cosmetics, herbal products, food supplements or medical devices.


Scilife, previously called QualityKick, is a Software as a Service (SaaS) solution for companies in the Pharma, Biotech and Medical Devices sectors to efficiently manage everything quality, process and product related, always according to the relevant compliance regulations.

Health to market

Health to Market is a contract commercialization organization in life sciences for Start-ups wanting to commercialize their product (go-to-market), Scale-ups wanting to take the next growth step, and Mature organizations failing to grow.  We help them define an effective commercial strategy and support their business development. H2M is a joint venture of Inovigate and QbD.


Persomed develops an innovative, personalized vaccine against colon cancer.


SIMABS is a contract development and manufacturing organisation for monoclonal antibodies. We deliver fast, flexible and cost-effective total solutions for your development and manufacturing by means of a new and unique manufacturing platform based on continuous bioprocessing.


Antleron wants to improve healthcare to ensure a better life for everyone. This innovative engineering company combines the potential of cells, biomaterials, biologics, 3D printing and bioreactors. As a result, it accelerates products, processes and technology in the life sciences industry.

QbD Partners


PILS – also known as ‘Partners in Life Sciences’ – is a new partnership between Flemish companies that offer services and products in life sciences. PILS’ ambition is to improve the footprint of smaller companies towards big pharma. 


ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest non-profit association that serves its members with leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. QbD’s CEO Bart Van Acker is Vice President of ISPE Belgium.


Flanders.bio is the networking organisation for the life sciences sector in Flanders. It’s a dynamic, non-profit, free-based organisation with currently more than 300 members. Bart Van Acker is a member of the board at Flanders.bio. Since the beginning of 2019, QbD set up a strategic partnership with Flanders.bio.


Amelior helps companies set up efficient management systems by means of training, advice and assistance. It specialises in quality, safety and well-being at work, logistics and production. QbD provides Amelior training programmes for GAMP 5® (ISPE), GLP and GMP in the (bio-)pharmaceutical industry.


HollandBIO is a fast-growing, privately funded interest group that represents the Dutch biotech industry. It unites various stakeholders throughout the sector: from start-ups and small to medium-sized enterprises to large companies – all of them active in health, nutrition or bio-based economy. HollandBIO’s activities include advocacy, organising networking activities, various member services and PR.

European Social Fund

With the support of the European Union and the Flemish Government, the European Social Fund (ESF) invests in job opportunities and quality careers. Thanks to their support, QbD is currently working on two projects to help employees develop their talents.


QbD is a partner of pharma.be, the federation of the innovative biopharmaceutical industry in Belgium, represents over 130 companies and 35.000 employees active in human healthcare in Belgium. As a full partner of physicians, pharmacists, hospitals, governments and other stakeholders, pharma.be has the mission to promote better health care through therapeutic innovation in the domain of medicinal products for human and veterinary use. 


Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, IVD & other health related products. 



BioWin is the Health Cluster of Wallonia, Belgium, the regional reference holder for all stakeholders in health biotech and medtech research and innovation projects.

The BioWin competitiveness cluster brings together all the innovation system players in the field of health (biopharma and medtech) in Wallonia, with the goal of stimulating regional economic redeployment.